BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14621125)

  • 1. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation.
    Scolapio JS; DeArment J; Hurley DL; Romano M; Harnois D; Weigand SD
    JPEN J Parenter Enteral Nutr; 2003; 27(6):427-32. PubMed ID: 14621125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
    Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
    Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatment.
    Krol CG; Dekkers OM; Kroon HM; Rabelink TJ; van Hoek B; Hamdy NA
    J Bone Miner Res; 2014 Aug; 29(8):1763-9. PubMed ID: 24644003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.
    Casez JP; Lippuner K; Horber FF; Montandon A; Jaeger P
    Nephrol Dial Transplant; 2002 Jul; 17(7):1318-26. PubMed ID: 12105258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density in the long term after liver transplantation.
    Hamburg SM; Piers DA; van den Berg AP; Slooff MJ; Haagsma EB
    Osteoporos Int; 2000; 11(7):600-6. PubMed ID: 11069194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
    Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
    Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
    Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
    Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
    Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
    Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen.
    Mart íG; Gómez R; Jódar E; Loinaz C; Moreno E; Hawkins E
    Osteoporos Int; 2002; 13(2):147-50. PubMed ID: 11905524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martínez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 2001 Feb; 68(2):83-6. PubMed ID: 11310351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
    Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
    J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol.
    Stempfle HU; Werner C; Siebert U; Assum T; Wehr U; Rambeck WA; Meiser B; Theisen K; Gärtner R
    Transplantation; 2002 Feb; 73(4):547-52. PubMed ID: 11889427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of serial changes of bone mineral density at lumbar spine and femoral neck before and after liver transplantation.
    Xu H; Eichstaedt H
    Chin Med J (Engl); 1999 Apr; 112(4):379-81. PubMed ID: 11593545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
    Laway BA; Goswami R; Singh N; Gupta N; Seith A
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
    Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM
    J Rheumatol; 1997 Aug; 24(8):1489-94. PubMed ID: 9263140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.